Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketotifen 4.0% Patch in Allergic Conjunctivitis
NCT00836485Phase 2Completed
- Sponsor
- Senju Pharmaceutical Co., Ltd.
- Start
- Feb 2009
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketotifen in allergic conjunctivitis (AC), sponsored by Senju Pharmaceutical Co., Ltd.. Started Feb 2009; status: completed.
02
Drugs
ketotifen
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT00836485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00836485.